May 10 (Reuters) - Aurinia Pharmaceuticals Inc AUP.TO :
* AURINIA REPORTS FIRST QUARTER FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
* AURINIA PHARMACEUTICALS INC - AURORA PHASE III TRIAL IN LUPUS NEPHRITIS REMAINS ON TRACK
* AURINIA PHARMACEUTICALS INC - CONTINUE TO BE WELL-CAPITALIZED INTO 2020
* AURINIA PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.18